Generics - Production


Current filters:


Popular Filters

51 to 75 of 107 results

Leading Indian drugmakers eye pharma production in Russia


Several top Indian drugmakers and suppliers, including Dr Reddy's (NYSE: RDY), Ranbaxy (BSE: 500359),…

Asia-PacificAurobindo PharmaCiplaDr Reddy's LaboratoriesEuropeGenericsProductionRanbaxy Laboratories

EU falsified medicines directive: imported active substances need written confirmation to guarantee GMP standards


From July 2, 2013, all active substances manufactured outside of the European Union and imported into…


Waiver from European Commission to help exporting for US pharmaceutical manufacturers


The US Food and Drug Administration announced on Friday (June 21) that the USA is now a "listed country"…

EuropeGenericsNorth AmericaPharmaceuticalProductionRegulation

China forms global alliance with Germany's blue inspection for drug quality


Effective June 1, 2013, the China Chamber of Commerce for Import & Export of Medicines & Health Products…


FDA warns Novartis on Austrian generic manufacturing plant cGMP failures


The US Food and Drug Administration has written to Joseph Jimenez, chief executive of Swiss drug major…

Ebewe PharmaGenericsNovartisProductionRegulationSandoz

Fujifilm and Dr Reddy's abandon plans for generics JV in Japan


Japan's Fujifilm Corp and Indian drugmaker Dr Reddy's Laboratories (NYSE: RDY) have decided to terminate…

Dr Reddy's LaboratoriesFujifilmGenericsMergers & AcquisitionsProduction

CPhI Russia highlights growth in domestic manufacturing and international partnering


Presentations at the CPhI Russia event which took place in April reflected growth in the Russian pharma…


Switzerland's Lonza involvement in South Africa pharma project in doubt


The South Africa government is expected to publish a request for information from potential international,…

Anti-viralsGenericsLonzaNovartisProductionRest of the World

Ranbaxy highlights its actions on improved business and quality assurance


Indian drugmaker Ranbaxy Laboratories (BSE: 500359), whose US subsidiary was the subject of the biggest…

Daiichi SankyoGenericsManagementProductionRanbaxy LaboratoriesRegulation

Boehringer Ingelheim gets FDA warning letter on cGMP failures


German family-owned drug major Boehringer Ingelheim today (May 22) revealed that the US Food and Drug…

Boehringer IngelheimGenericsPharmaceuticalProductionRegulation

US DoJ says Ranbaxy pleads guilty and agrees to pay $500 million in settlements


In the largest drug safety settlement to date with a generic drug manufacturer, Ranbaxy USA, a subsidiary…

Asia-PacificDaiichi SankyoFinancialGenericsLegalNorth AmericaProductionRanbaxy LaboratoriesRegulation

Africa's pharmaceutical industry faces numerous challenges, VoA reports


Providing Africans with affordable health care could be realized if pharmaceutical products were produced…

Asia-PacificGenericsHealthcarePharmaceuticalProductionRest of the World

ScinoPharm Taiwan and Coland in strategic alliance for generic oncology injectables


ScinoPharm Taiwan (TSE: 1789.TW) and Coland Holdings (TSE: 4144.TW) have formed a strategic alliance…


Canada strengthens drug safety with GMP now to apply to all APIs


Canada's Health Minister Leona Aglukkaq this week announced that Canada's Food and Drug Regulations have…

GenericsNorth AmericaPharmaceuticalProductionRegulation

Sagent Pharma to buy remaining 50% stake in Chinese JV for $25 million


US specialty pharmaceutical company Sagent Pharmaceuticals (Nasdaq: SGNT) has entered into an agreement…

Asia-PacificGenericsKanghong Sagent (Chengdu) PharmaceuticalMergers & AcquisitionsPharmaceuticalProductionSagent Pharmaceuticals

Italy's Chiesi eyes Russian expansion


Privately held Italian drugmaker Chiesi Farmaceutici is considering a massive expansion into the Russian…

Chiesi FarmaceuticiEuropeGenericsMarkets & MarketingPharmstandardProductionRespiratory and Pulmonary

Argentina's pharma market to almost triple over one decade, says GlobalData


Argentina's pharmaceutical market is expected to grow from a value of around $5.6 billion in 2012 to…

GenericsMarkets & MarketingPatentsPharmaceuticalProductionRegulationSouth America

Pfenex and Agila Biotech set up JV to develop biosimilars


US biotech firm Pfenex Inc. and Agila Biotech, a subsidiary of Indian drugmaker Strides Arcolab (BO:…

Agila BiotechBayerBetaferonBetaseronBiotechnologyGenericsGlobalNeurologicalPfenexProductionResearchStrides Arcolab

Both biosimilar and reference biologics companies must consider product-specific and regional strategies


With sales forecasted to exceed $16.8 billion by 2021, manufacturers competing in the biosimilars market…

BiotechnologyGenericsMarkets & MarketingPatentsProductionResearch

Russia's Biocad plans to produce high-tech drugs in Brazil


Biocad, one of Russia's leading biotechnology companies, plans to launch production of several of its…

AvastinBiocadBiotechnologyGenericsHerceptinMabTheraOncologyProductionRocheSouth America

Public Citizen slams FDA over lax oversight of "compounding pharmacies"


Strengthened enforcement over compounding pharmacies that act as drug manufacturers would help alleviate…

GenericsNorth AmericaPharmaceuticalProductionRegulation

India's Cadila Pharmaceuticals eyes building plant in Russia


Cadila Pharmaceuticals, one of the largest privately held pharmaceutical companies in India, is considering…

Cadila PharmaceuticalsEuropeGenericsProduction

Neuland Labs in deal with Mitsubishi unit to strengthen Japanese position


Indian active pharmaceutical ingredients maker Neuland Laboratories (BO:524558) has announced a manufacturing…

API CorpAsia-PacificGenericsMitsubishi ChemicalNeuland LaboratoriesProduction

Indian Pharma growth outpaces rivals, but must embrace innovation


Ranking among the top five globally by production volume, the Indian pharmaceutical market at present…

Asia-PacificBiotechnologyGenericsMarkets & MarketingPharmaceuticalProductionResearch

51 to 75 of 107 results

Back to top